NCT06632951
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06632951
Title Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC) (LIVIGNO-3)
Acronym LIVIGNO-3
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ISR | FRA | ESP | CAN

Facility Status City State Zip Country Details
Highlands Oncology Group - Springdale /ID# 270290 Springdale Arkansas 72762 United States Details
University of California San Francisco - Mission Bay /ID# 270289 San Francisco California 94158 United States Details
Yale University School of Medicine /ID# 270449 New Haven Connecticut 06510 United States Details
Medical Oncology Hematology Consultants /ID# 271347 Newark Delaware 19713 United States Details
Florida Cancer Specialists - North /ID# 271215 St. Petersburg Florida 33705 United States Details
Icahn School of Medicine at Mount Sinai /ID# 270272 New York New York 10029 United States Details
University Hospitals Cleveland Medical Center /ID# 271010 Cleveland Ohio 44106 United States Details
The Ohio State University /ID# 271349 Columbus Ohio 43210 United States Details
SCRI Oncology Partners /ID# 270439 Nashville Tennessee 37203 United States Details
Texas Oncology - Austin Central /ID# 271284 Austin Texas 78731 United States Details
Utah Cancer Specialist /ID# 270810 Salt Lake City Utah 84124 United States Details
Centre Hospitalier Affilié Universitaire de Québec - Hôpital de l'Enfant-Jésus /ID# 271635 Québec Quebec G1J 1Z4 Canada Details
Institut Paoli-Calmettes /ID# 270580 Marseille Bouches-du-Rhone 13273 France Details
Hôpital Foch /ID# 270573 Suresnes Hauts-de-Seine 92151 France Details
Institut Gustave Roussy /ID# 270575 Villejuif Île-de-France Region 94800 France Details
Meir Medical Center /ID# 270108 Kfar Saba Central District 4428164 Israel Details
The Chaim Sheba Medical Center /ID# 270096 Ramat Gan Tel Aviv 5265601 Israel Details
Tel Aviv Sourasky Medical Center /ID# 270106 Tel Aviv Tel Aviv 6423906 Israel Details
Rambam Health Care Campus /ID# 270105 Haifa 3525408 Israel Details
Rabin Medical Center /ID# 270107 Petah Tikva 4941492 Israel Details
Hirosaki University Hospital /ID# 270531 Hirosaki Aomori 036-8563 Japan Details
Fukushima Medical University Hospital /ID# 270752 Fukushima Fukushima 960-1295 Japan Details
University of Tsukuba Hospital /ID# 270354 Tsukuba Ibaraki 305-8576 Japan Details
Kanazawa University Hospital /ID# 270473 Kanazawa Ishikawa-ken 920-8641 Japan Details
Aidport Sp. z o.o. /ID# 270049 Skórzewo Greater Poland Voivodeship 60-185 Poland Details
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Bada /ID# 270046 Warsaw Masovian Voivodeship 02-781 Poland Details
National Cancer Center /ID# 270453 Goyang-si Gyeonggido 10408 South Korea Details
Chonnam National University Hwasun Hospital /ID# 271299 Hwasun-gun Jeonranamdo 58128 South Korea Details
Yonsei University Health System Severance Hospital /ID# 270317 Seoul Seoul Teugbyeolsi 03722 South Korea Details
Asan Medical Center /ID# 270898 Seoul Seoul Teugbyeolsi 05505 South Korea Details
Samsung Medical Center /ID# 270318 Seoul Seoul Teugbyeolsi 06351 South Korea Details
Parc de Salut Mar - Hospital del Mar /ID# 270173 Barcelona 08003 Spain Details
Hospital Universitario Vall d'Hebron /ID# 269783 Barcelona 08035 Spain Details
Hospital Clinic de Barcelona /ID# 269789 Barcelona 08036 Spain Details
Hospital MD Anderson Cancer Center Madrid /ID# 269780 Madrid 28033 Spain Details
Hospital Clinico San Carlos /ID# 269786 Madrid 28040 Spain Details
Hospital Universitario Virgen del Rocio /ID# 269782 Seville 41013 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field